Modification of the Suprachoroidal Buckling Technique for the Treatment of Rhegmatogenous Retinal Detachment

Abstract

PURPOSE: To describe modification of the suprachoroidal buckling technique for the treatment of rhegmatogenous retinal detachment (RRD) which may improve the safety profile. METHODS: A single-surgeon foot-pedal-controlled automated suprachoroidal injection (SCI) of sodium hyaluronate 1%, namely ProVisc® (Alcon Laboratories, Fort Worth, TX, USA) was used for the treatment of RRD. MicroDose™ Injection Kit (MedOne Surgical, Sarasota, FL, USA) including connector and 1 mL syringe, designed for subretinal injection, was used to adapt Constellation® Vision System (Alcon Laboratories, Fort Worth, TX, USA) vitrectomy console for SCI of ProVisc® from the 1 mL syringe. RESULTS: This approach enables better surgeon control during SCI. Three highly myopic eyes of three patients with primary macula-on RRD and single superior peripheral retinal break were treated. Complete retinal reattachment was achieved in all eyes without complications. CONCLUSION: Injecting ProVisc® under foot-pedal control provides a more precise and potentially safer suprachoroidal buckling technique compared to manual technique with more variable injection speed and pressure.